Pro-Dex Inc New vs. ResMed Inc.
ResMed Inc. (RMD) comes out ahead, leading on 6 of 9 compared factors.
Size & Scale
| PDEX | RMD | |
|---|---|---|
| Market Cap | $214.39 million | $31.79 billion |
| Revenue (TTM) | $72.10 million | $5.65 billion |
| Net Income (TTM) | $2.52 million | $1.52 billion |
RMD leads on 3 of 3 size & scale factors.
Valuation
| PDEX | RMD | |
|---|---|---|
| P/E Ratio | 19.62 | 21.09 |
| Price / Book | 5.15 | 4.83 |
| Price / Sales | 2.97 | 5.62 |
PDEX leads on 2 of 3 valuation factors.
Profitability
| PDEX | RMD | |
|---|---|---|
| Net Margin | 3.49% | 26.94% |
| Return on Equity | 6.04% | 23.13% |
RMD leads on 2 of 2 profitability factors.
Dividend
| PDEX | RMD | |
|---|---|---|
| Dividend Yield | — | 1.20% |
| Payout Ratio | — | 25.31 |
PDEX and RMD split the dividend factors evenly.
Risk & Sentiment
| PDEX | RMD | |
|---|---|---|
| Short Interest | 0.14% | 4.02% |
PDEX leads on 1 of 1 risk & sentiment factors.
Dig deeper: PDEX overview, PDEX financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.